Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 403

1.

K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution.

Leske H, Rushing E, Budka H, Niehusmann P, Pahnke J, Panagopoulos I.

Acta Neuropathol. 2018 Jul;136(1):175-176. doi: 10.1007/s00401-018-1867-2. Epub 2018 May 15. No abstract available.

PMID:
29766298
2.

Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis.

Al Nimer F, Jelcic I, Kempf C, Pieper T, Budka H, Sospedra M, Martin R.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e419. doi: 10.1212/NXI.0000000000000419. eCollection 2018 Jan.

3.

Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome.

Kirschenbaum D, Hedberg-Oldfors C, Oldfors A, Scherer E, Budka H.

Neuropathol Appl Neurobiol. 2018 Oct;44(6):639-642. doi: 10.1111/nan.12429. No abstract available.

4.

Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).

Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, Budka H, Dickson DW, Dugger BN, Duyckaerts C, Ferrer I, Forrest SL, Gelpi E, Gentleman SM, Giaccone G, Grinberg LT, Halliday GM, Hatanpaa KJ, Hof PR, Hofer M, Hortobágyi T, Ironside JW, King A, Kofler J, Kövari E, Kril JJ, Love S, Mackenzie IR, Mao Q, Matej R, McLean C, Munoz DG, Murray ME, Neltner J, Nelson PT, Ritchie D, Rodriguez RD, Rohan Z, Rozemuller A, Sakai K, Schultz C, Seilhean D, Smith V, Tacik P, Takahashi H, Takao M, Rudolf Thal D, Weis S, Wharton SB, White CL 3rd, Woulfe JM, Yamada M, Trojanowski JQ.

J Neuropathol Exp Neurol. 2017 Jul 1;76(7):605-619. doi: 10.1093/jnen/nlx041.

5.

Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease.

Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG, Budka H, Avrahami D, Gabizon R.

PLoS Pathog. 2017 May 3;13(5):e1006294. doi: 10.1371/journal.ppat.1006294. eCollection 2017 May.

6.

SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions.

Akiguchi I, Pallàs M, Budka H, Akiyama H, Ueno M, Han J, Yagi H, Nishikawa T, Chiba Y, Sugiyama H, Takahashi R, Unno K, Higuchi K, Hosokawa M.

Neuropathology. 2017 Aug;37(4):293-305. doi: 10.1111/neup.12373. Epub 2017 Mar 6. Review.

PMID:
28261874
7.

Cystatin F is a biomarker of prion pathogenesis in mice.

Nuvolone M, Schmid N, Miele G, Sorce S, Moos R, Schori C, Beerli RR, Bauer M, Saudan P, Dietmeier K, Lachmann I, Linnebank M, Martin R, Kallweit U, Kana V, Rushing EJ, Budka H, Aguzzi A.

PLoS One. 2017 Feb 8;12(2):e0171923. doi: 10.1371/journal.pone.0171923. eCollection 2017.

8.

Fatal cerebral haemorrhage in a hypertensive seven-year-old boy.

Brandtner H, Monticelli FC, Meyer HJ, Biebl A, Budka H.

JRSM Open. 2016 Sep 1;7(9):2054270416649284. doi: 10.1177/2054270416649284. eCollection 2016 Sep.

9.

Tau pathology in Creutzfeldt-Jakob disease revisited.

Kovacs GG, Rahimi J, Ströbel T, Lutz MI, Regelsberger G, Streichenberger N, Perret-Liaudet A, Höftberger R, Liberski PP, Budka H, Sikorska B.

Brain Pathol. 2017 May;27(3):332-344. doi: 10.1111/bpa.12411. Epub 2016 Aug 2.

PMID:
27377321
10.

Neuropathological criteria of anti-IgLON5-related tauopathy.

Gelpi E, Höftberger R, Graus F, Ling H, Holton JL, Dawson T, Popovic M, Pretnar-Oblak J, Högl B, Schmutzhard E, Poewe W, Ricken G, Santamaria J, Dalmau J, Budka H, Revesz T, Kovacs GG.

Acta Neuropathol. 2016 Oct;132(4):531-43. doi: 10.1007/s00401-016-1591-8. Epub 2016 Jun 29.

11.

Dura mater is a potential source of Aβ seeds.

Kovacs GG, Lutz MI, Ricken G, Ströbel T, Höftberger R, Preusser M, Regelsberger G, Hönigschnabl S, Reiner A, Fischer P, Budka H, Hainfellner JA.

Acta Neuropathol. 2016 Jun;131(6):911-23. doi: 10.1007/s00401-016-1565-x. Epub 2016 Mar 25.

12.

Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.

Jelcic I, Jelcic I, Kempf C, Largey F, Planas R, Schippling S, Budka H, Sospedra M, Martin R.

Ann Neurol. 2016 Mar;79(3):404-18. doi: 10.1002/ana.24574. Epub 2016 Feb 13.

13.

Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Frontzek K, Lutz MI, Aguzzi A, Kovacs GG, Budka H.

Swiss Med Wkly. 2016 Jan 26;146:w14287. doi: 10.4414/smw.2016.14287. eCollection 2016.

14.

The end of the BSE saga: do we still need surveillance for human prion diseases?

Budka H, Will RG.

Swiss Med Wkly. 2015 Nov 12;145:w14212. doi: 10.4414/smw.2015.14212. eCollection 2015. Review.

15.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

16.

Iatrogenic and sporadic Creutzfeldt-Jakob disease in 2 sisters without mutation in the prion protein gene.

Frontzek K, Moos R, Schaper E, Jann L, Herfs G, Zimmermann DR, Aguzzi A, Budka H.

Prion. 2015;9(6):444-8. doi: 10.1080/19336896.2015.1121356.

17.

Structure-based drug design identifies polythiophenes as antiprion compounds.

Herrmann US, Schütz AK, Shirani H, Huang D, Saban D, Nuvolone M, Li B, Ballmer B, Åslund AK, Mason JJ, Rushing E, Budka H, Nyström S, Hammarström P, Böckmann A, Caflisch A, Meier BH, Nilsson KP, Hornemann S, Aguzzi A.

Sci Transl Med. 2015 Aug 5;7(299):299ra123. doi: 10.1126/scitranslmed.aab1923.

PMID:
26246168
18.

A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.

Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V, Ponto C, Calero O, Poleggi A, Carracedo Á, van der Lee SJ, Ströbel T, Rivadeneira F, Hofman A, Haïk S, Combarros O, Berciano J, Uitterlinden AG, Collins SJ, Budka H, Brandel JP, Laplanche JL, Pocchiari M, Zerr I, Knight RS, Will RG, van Duijn CM.

PLoS One. 2015 Apr 28;10(4):e0123654. doi: 10.1371/journal.pone.0123654. eCollection 2014.

19.

Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?

Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W.

J Neuropathol Exp Neurol. 2015 Mar;74(3):194-7. doi: 10.1097/NEN.0000000000000173.

20.

A case of variably protease-sensitive prionopathy treated with doxycyclin.

Assar H, Topakian R, Weis S, Rahimi J, Trenkler J, Höftberger R, Aboulenein-Djamshidian F, Ströbel T, Budka H, Yull H, Head MW, Ironside JW, Kovacs GG.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):816-8. doi: 10.1136/jnnp-2014-309871. Epub 2015 Jan 9. No abstract available.

21.

The role of the NADPH oxidase NOX2 in prion pathogenesis.

Sorce S, Nuvolone M, Keller A, Falsig J, Varol A, Schwarz P, Bieri M, Budka H, Aguzzi A.

PLoS Pathog. 2014 Dec 11;10(12):e1004531. doi: 10.1371/journal.ppat.1004531. eCollection 2014 Dec.

22.

MRI features of Binswanger's disease predict prognosis and associated pathology.

Akiguchi I, Budka H, Shirakashi Y, Woehrer A, Watanabe T, Shiino A, Yamamoto Y, Kawamoto Y, Krampla W, Jungwirth S, Fischer P.

Ann Clin Transl Neurol. 2014 Oct;1(10):813-21. doi: 10.1002/acn3.123. Epub 2014 Oct 6.

23.

Disproportionate subarachnoid space hydrocephalus-outcome and perivascular space.

Akiguchi I, Shirakashi Y, Budka H, Watanabe Y, Watanabe T, Shiino A, Ogita M, Kawamoto Y, Jungwirth S, Krampla W, Fischer P.

Ann Clin Transl Neurol. 2014 Aug;1(8):562-9. doi: 10.1002/acn3.87. Epub 2014 Jul 28.

24.

Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread.

Kovacs GG, Breydo L, Green R, Kis V, Puska G, Lőrincz P, Perju-Dumbrava L, Giera R, Pirker W, Lutz M, Lachmann I, Budka H, Uversky VN, Molnár K, László L.

Neurobiol Dis. 2014 Sep;69:76-92. doi: 10.1016/j.nbd.2014.05.020. Epub 2014 May 27.

PMID:
24878508
25.

ASSOCIATION OF TEMPORAL LOBE INFLAMMATORY LEUKOENCEPHALOPATHY WITH TWO B CELL MALIGNANCIES.

Garzuly F, Hahn K, Iványi LJ, Kereskai L, Gábor V, Kovács GG, Budka H, Kalman B.

Ideggyogy Sz. 2014 Mar 30;67(3-4):135-9.

PMID:
26118258
26.

Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?

Kovacs GG, Peden A, Weis S, Höftberger R, Berghoff AS, Yull H, Ströbel T, Koppi S, Katzenschlager R, Langenscheidt D, Assar H, Zaruba E, Gröner A, Voigtländer T, Puska G, Hametner E, Grams A, Muigg A, Knoflach M, László L, Ironside JW, Head MW, Budka H.

Acta Neuropathol Commun. 2013 Nov 11;1:72. doi: 10.1186/2051-5960-1-72.

27.

Globular glial tauopathies (GGT): consensus recommendations.

Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, Giaccone G, Hatanpaa KJ, Holton JL, Josephs KA, Powers J, Spina S, Takahashi H, White CL 3rd, Revesz T, Kovacs GG.

Acta Neuropathol. 2013 Oct;126(4):537-544. doi: 10.1007/s00401-013-1171-0. Epub 2013 Aug 31.

28.

Intensity of human prion disease surveillance predicts observed disease incidence.

Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, Matěj R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, Brandel JP, Alperovitch A, Budka H, Kovacs GG, Jansen GH, Coulthard M, Collins SJ.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1372-7. doi: 10.1136/jnnp-2012-304820. Epub 2013 Aug 21.

PMID:
23965290
29.

Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.

Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H.

Acta Neuropathol. 2013 Sep;126(3):365-84. doi: 10.1007/s00401-013-1157-y. Epub 2013 Jul 31.

PMID:
23900711
30.

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.

Schippling S, Kempf C, Büchele F, Jelcic I, Bozinov O, Bont A, Linnebank M, Sospedra M, Weller M, Budka H, Martin R.

Ann Neurol. 2013 Oct;74(4):622-6. doi: 10.1002/ana.23973. Epub 2013 Sep 16.

PMID:
23868420
31.

Imported human rabies in Switzerland, 2012: a diagnostic conundrum.

Deubelbeiss AN, Trachsel Ch, Bachli EB, Kuffer A, Budka H, Eniseyskiy P, Zimmermann H, Wallace RM, Farley S, Zanoni RG.

J Clin Virol. 2013 Jun;57(2):178-81. doi: 10.1016/j.jcv.2013.02.001. Epub 2013 Feb 26.

PMID:
23485347
32.

Cerebellar dysfunction in a family harboring the PSEN1 mutation co-segregating with a cathepsin D variant p.A58V.

Ehling R, Nosková L, Stránecký V, Hartmannová H, Přistoupilová A, Hodaňová K, Benke T, Kovacs GG, Ströbel T, Niedermüller U, Wagner M, Nachbauer W, Janecke A, Budka H, Boesch S, Kmoch S.

J Neurol Sci. 2013 Mar 15;326(1-2):75-82. doi: 10.1016/j.jns.2013.01.017. Epub 2013 Feb 13.

PMID:
23415546
33.

Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.

Wanschitz JV, Dubourg O, Lacene E, Fischer MB, Höftberger R, Budka H, Romero NB, Eymard B, Herson S, Butler-Browne GS, Voit T, Benveniste O.

Neuromuscul Disord. 2013 Jan;23(1):75-83. doi: 10.1016/j.nmd.2012.09.003. Epub 2012 Oct 9.

34.

External granular cell layer bobbling: a distinct histomorphological feature of the developing human cerebellum.

Gelpi E, Budka H, Preusser M.

Clin Neuropathol. 2013 Jan-Feb;32(1):42-50. doi: 10.5414/NP300518.

PMID:
22943957
35.

Stabilization of a prion strain of synthetic origin requires multiple serial passages.

Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV.

J Biol Chem. 2012 Aug 31;287(36):30205-14. doi: 10.1074/jbc.M112.392985. Epub 2012 Jul 17.

36.

The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium.

Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Höftberger R, Ironside JW, Jellinger K, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

Exp Gerontol. 2012 Nov;47(11):825-33. doi: 10.1016/j.exger.2012.06.001. Epub 2012 Jun 15.

PMID:
22705312
37.

A new mechanism for transmissible prion diseases.

Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Ostapchenko VG, Budka H, Rohwer RG, Baskakov IV.

J Neurosci. 2012 May 23;32(21):7345-55. doi: 10.1523/JNEUROSCI.6351-11.2012.

38.

Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.

Mikol J, Deslys JP, Zou WQ, Xiao W, Brown P, Budka H, Goutieres F.

Clin Neuropathol. 2012 May-Jun;31(3):127-34.

39.

Prion protein (PrP) deposits in the tectum of experimental Gerstmann-Sträussler-Scheinker disease following intraocular inoculation.

Liberski PP, Hainfellner JA, Sikorska B, Budka H.

Folia Neuropathol. 2012;50(1):85-8. Review.

40.

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bódi I, King A, Hortobágyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H.

Neuropathol Appl Neurobiol. 2013 Feb;39(2):166-78. doi: 10.1111/j.1365-2990.2012.01272.x.

PMID:
22471883
41.

Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Friedman-Levi Y, Hoftberger R, Budka H, Mayer-Sonnenfeld T, Abramsky O, Ovadia H, Gabizon R.

J Neuroinflammation. 2012 Mar 21;9:58. doi: 10.1186/1742-2094-9-58.

42.

Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia.

Woehrer A, Laszlo L, Finsterer J, Stöllberger C, Furtner J, Rinner W, Molnar K, Budka H, Kovacs GG.

Acta Neuropathol. 2012 Oct;124(4):583-91. doi: 10.1007/s00401-012-0965-9. Epub 2012 Mar 7.

PMID:
22392442
43.

An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.

Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, Leisser I, Verchère J, Baron T, Alafuzoff I, Budka H, Perret-Liaudet A, Lachmann I.

Acta Neuropathol. 2012 Jul;124(1):37-50. doi: 10.1007/s00401-012-0964-x. Epub 2012 Feb 28.

PMID:
22370907
44.

Advocacy for neuropathology in practice: ISN information days.

Budka H, Scaravilli F.

Brain Pathol. 2012 Mar;22(2):i. doi: 10.1111/j.1750-3639.2012.00567.x. No abstract available.

PMID:
22369108
45.

Intraneuronal immunoreactivity for the prion protein distinguishes a subset of E200K genetic from sporadic Creutzfeldt-Jakob Disease.

Kovacs GG, Molnár K, Keller E, Botond G, Budka H, László L.

J Neuropathol Exp Neurol. 2012 Mar;71(3):223-32. doi: 10.1097/NEN.0b013e318248aa70.

PMID:
22318125
46.

Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.

Venkataramani V, Wirths O, Budka H, Härtig W, Kovacs GG, Bayer TA.

J Alzheimers Dis. 2012;29(2):361-71. doi: 10.3233/JAD-2011-111379.

PMID:
22232007
47.

Asymmetry of neurodegenerative disease-related pathologies: a cautionary note.

Stefanits H, Budka H, Kovacs GG.

Acta Neuropathol. 2012 Mar;123(3):449-52. doi: 10.1007/s00401-011-0936-6. Epub 2012 Jan 6. No abstract available.

PMID:
22222584
48.

Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.

Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV.

PLoS Pathog. 2011 Dec;7(12):e1002419. doi: 10.1371/journal.ppat.1002419. Epub 2011 Dec 1.

49.

Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease.

Friedman-Levi Y, Meiner Z, Canello T, Frid K, Kovacs GG, Budka H, Avrahami D, Gabizon R.

PLoS Pathog. 2011 Nov;7(11):e1002350. doi: 10.1371/journal.ppat.1002350. Epub 2011 Nov 3. Erratum in: PLoS Pathog. 2017 May 3;13(5):e1006294.

50.

Multiple intracranial cavernomas with focal amyloid deposition - diagnostic pitfalls.

Velnar T, Bunc G, Flisar D, Kulaš D, Woehrer A, Budka H, Popoviä M.

Clin Neuropathol. 2011 Nov-Dec;30(6):324-7.

Supplemental Content

Support Center